Hodgkin Disease

"Hodgkin Disease" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

A malignant disease characterized by progressive enlargement of the lymph nodes, spleen, and general lymphoid tissue. In the classical variant, giant usually multinucleate Hodgkin's and REED-STERNBERG CELLS are present; in the nodular lymphocyte predominant variant, lymphocytic and histiocytic cells are seen.

Descriptor ID	D006689
MeSH Number(s)	C04.557.386.355 C15.604.515.569.355 C20.683.515.761.355
Concept/Terms	Hodgkin Disease Hodgkin Disease Disease, Hodgkin Granuloma, Hodgkin's Hodgkin's Granuloma Granuloma, Hodgkins Hodgkins Granuloma Lymphogranuloma, Malignant Lymphogranulomas, Malignant Malignant Lymphogranuloma Malignant Lymphogranulomas Hodgkin Lymphoma Lymphoma, Hodgkin Hodgkin's Disease Disease, Hodgkin's Hodgkin's Lymphoma Hodgkins Lymphoma Lymphoma, Hodgkin's Hodgkins Disease Disease, Hodgkins Granuloma, Hodgkin Hodgkin Granuloma Granuloma, Malignant Malignant Granuloma Malignant Granulomas Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Nodular Lymphocyte-Predominant Hodgkin's Lymphoma Nodular Lymphocyte Predominant Hodgkin's Lymphoma Nodular Sclerosing Hodgkin's Lymphoma Lymphocyte-Rich Classical Hodgkin's Lymphoma Lymphocyte-Rich Classical Hodgkin's Lymphoma Lymphocyte Rich Classical Hodgkin's Lymphoma Mixed Cellularity Hodgkin's Lymphoma Mixed Cellularity Hodgkin's Lymphoma Hodgkin Lymphoma, Adult Hodgkin Lymphoma, Adult Adult Hodgkin Lymphoma Lymphocyte Depletion Hodgkin's Lymphoma Lymphocyte Depletion Hodgkin's Lymphoma

Below are MeSH descriptors whose meaning is more general than "Hodgkin Disease".

Diseases [C]
Neoplasms [C04]
Neoplasms by Histologic Type [C04.557]
Lymphoma [C04.557.386]
Hodgkin Disease [C04.557.386.355]
Hemic and Lymphatic Diseases [C15]
Lymphatic Diseases [C15.604]
Lymphoproliferative Disorders [C15.604.515]
Lymphoma [C15.604.515.569]
Hodgkin Disease [C15.604.515.569.355]
Immune System Diseases [C20]
Immunoproliferative Disorders [C20.683]
Lymphoproliferative Disorders [C20.683.515]
Lymphoma [C20.683.515.761]
Hodgkin Disease [C20.683.515.761.355]

Below are MeSH descriptors whose meaning is related to "Hodgkin Disease".

Below are MeSH descriptors whose meaning is more specific than "Hodgkin Disease".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Hodgkin Disease" by people in this website by year, and whether "Hodgkin Disease" was a major or minor topic of these publications.

Bar chart showing 67 publications over 27 distinct years, with a maximum of 6 publications in 2012 and 2013 and 2017

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1996	0	2	2
1997	2	0	2
1998	1	0	1
1999	0	1	1
2000	1	0	1
2001	1	0	1
2002	2	0	2
2003	1	0	1
2004	3	0	3
2005	3	0	3
2006	3	0	3
2007	4	0	4
2008	3	0	3
2009	1	0	1
2010	1	0	1
2011	2	0	2
2012	6	0	6
2013	5	1	6
2014	1	0	1
2015	0	1	1
2016	1	0	1
2017	6	0	6
2018	2	0	2
2019	3	0	3
2020	3	0	3
2021	4	0	4
2023	3	0	3

Below are the most recent publications written about "Hodgkin Disease" by people in Profiles.

Mellgard G, Stoffel E, Michel A, Iqbal F, Provenzano A, Akpan IJ, Amengual J, Pro B. Hypereosinophilic syndrome with leptomeningeal involvement: a not-so-classical case report of classical Hodgkin Lymphoma. Leuk Lymphoma. 2023 12; 64(13):2208-2213.

View in: PubMed
Allen PB, Lu X, Chen Q, O'Shea K, Chmiel JS, Slonim LB, Sukhanova M, Savas H, Evens AM, Advani R, Pro B, Karmali R, Palmer B, Bayer RA, Eisner RM, Mou E, Dillehay G, Gordon LI, Winter JN. Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma. Blood Adv. 2023 Jun 27; 7(12):2670-2676.

View in: PubMed
Bryan LJ, Casulo C, Allen PB, Smith SE, Savas H, Dillehay GL, Karmali R, Pro B, Kane KL, Bazzi LA, Chmiel JS, Palmer BA, Mehta J, Gordon LI, Winter JN. Pembrolizumab Added to Ifosfamide, Carboplatin, and Etoposide Chemotherapy for Relapsed or Refractory Classic Hodgkin Lymphoma: A Multi-institutional Phase 2 Investigator-Initiated Nonrandomized Clinical Trial. JAMA Oncol. 2023 05 01; 9(5):683-691.

View in: PubMed
Arter ZL, Meghpara S, Mignano S, Berenberg J. A Rare Coexistence of Seminoma and Hodgkin's Lymphoma in Hawai'i. Hawaii J Health Soc Welf. 2021 12; 80(12):295-297.

View in: PubMed
Davidow K, Bunin N, Goldfarb S, Li Y, Freedman JL. Pulmonary Outcomes After Autologous Stem Cell Transplant for Hodgkin Lymphoma. J Pediatr Hematol Oncol. 2022 08 01; 44(6):e926-e929.

View in: PubMed
Metzger ML, Link MP, Billett AL, Flerlage J, Lucas JT, Mandrell BN, Ehrhardt MJ, Bhakta N, Yock TI, Friedmann AM, de Alarcon P, Luna-Fineman S, Larsen E, Kaste SC, Shulkin B, Lu Z, Li C, Hiniker SM, Donaldson SS, Hudson MM, Krasin MJ. Excellent Outcome for Pediatric Patients With High-Risk Hodgkin Lymphoma Treated With Brentuximab Vedotin and Risk-Adapted Residual Node Radiation. J Clin Oncol. 2021 07 10; 39(20):2276-2283.

View in: PubMed
Allen PB, Savas H, Evens AM, Advani RH, Palmer B, Pro B, Karmali R, Mou E, Bearden J, Dillehay G, Bayer RA, Eisner RM, Chmiel JS, O'Shea K, Gordon LI, Winter JN. Pembrolizumab followed by AVD in untreated early unfavorable and advanced-stage classical Hodgkin lymphoma. Blood. 2021 03 11; 137(10):1318-1326.

View in: PubMed
Nagpal P, Descalzi-Montoya DB, Lodhi N. The circuitry of the tumor microenvironment in adult and pediatric Hodgkin lymphoma: cellular composition, cytokine profile, EBV, and exosomes. Cancer Rep (Hoboken). 2021 04; 4(2):e1311.

View in: PubMed
Damlaj M, Abuelgasim KA, Alhejazi A, Alahmari B, Alaskar A, Alzahrani M. Brentuximab vedotin containing salvage followed by consolidation post autologous hematopoietic stem cell transplantation in high risk relapsed refractory classical Hodgkin lymphoma. Bone Marrow Transplant. 2020 12; 55(12):2322-2325.

View in: PubMed
Gittens AT, Clarke JD, Abdelbaki S, Kwon JS. A 72-Year-Old Man With a Violaceous Rash?and Sepsis. Chest. 2020 02; 157(2):e41-e45.

View in: PubMed

People

Explore

Similar Concepts

Top Journals

The Thomas Jefferson University web site, its contents and programs, is provided for informational and educational purposes only and is not intended as medical advice nor is it intended to create any physician-patient relationship. Please remember that this information should not substitute for a visit or a consultation with a health care provider. The views or opinions expressed in the resources provided do not necessarily reflect those of Thomas Jefferson University, Thomas Jefferson University Hospital, or the Jefferson Health System or staff.
Please read our Privacy Statement